Evidence map›Paper›PMID 32669328›Full record

ArticleJournal of virology2020

Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.

Julia B McBrien, Andrew K H Wong, Erick White, Diane G Carnathan, John H Lee, Jeffrey T Safrit, Thomas H Vanderford, Mirko Paiardini, Ann Chahroudi, Guido Silvestri

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Latency Reversing Agents and the Road to an HIV CurePathogens (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. CD8Immunity · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Julia B McBrienEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Andrew K H WongEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Erick WhiteEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Diane G CarnathanEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
John H LeeNantKwest, Culver City, California, USA.
Jeffrey T SafritNantKwest, Culver City, California, USA.
Thomas H VanderfordEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Mirko PaiardiniEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Ann ChahroudiDepartment of Pediatrics, Emory University, Atlanta, Georgia, USA.
Guido SilvestriEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA gsilves@emory.edu.
Emory University · USImmunityBio (United States) · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection - Administrative SupplementUM1AI124436 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO, HUNTER, ERIC · 2016 to 2021
$42.3M
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaquesR01AI125064 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2016 to 2025
$8.7M
NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI125064NIAID NIH HHS UM1 AI124436NIH HHS P51 OD011132
6 · The paper itself

Abstract

The "shock and kill" strategy predicates that virus reactivation in latently infected cells is required to eliminate the human immunodeficiency virus (HIV) reservoir. In a recent study, we showed robust and persistent induction of plasma viremia in antiretroviral therapy (ART)-treated simian immunodeficiency virus-infected rhesus macaques (RMs) undergoing CD8α depletion and treated with the interleukin-15 (IL-15) superagonist N-803 (J. B. McBrien et al., Nature 578:154-159, 2020, https://doi.org/10.1038/s41586-020-1946-0). Of note, in that study we used an antibody targeting CD8α, thereby depleting NK cells, NKT cells, and γδ T cells, in addition to CD8

Indexed as

AnimalsAnti-Retroviral AgentsCD8 AntigensCD8-Positive T-LymphocytesDisease Models, AnimalHIVHIV InfectionsInterleukin-15Killer Cells, NaturalLymphocyte DepletionMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadViremiaVirus LatencyAnti-Retroviral AgentsCD8 AntigensCD8beta antigenInterleukin-15AIDSdepletionHIVIL-15immunologylatencyN-803reservoirSHIVSIV

Identifiers

PMID32669328
PMCPMC7495383
OpenAlexW3042229738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.